Comparison of Two Flow Rates of HHHFNC to Prevent Extubation Failure in Preterm Infants
HHHFNC to Prevent Extubation Failure in Preterm Infants: A Randomized Controlled Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
This is a randomized controlled trial (RCT) to evaluate the influence of two flow rates (6 liter/min versus 3 liter/min) of Heated-Humidified High-Flow-Nasal-Cannula (HHHFNC) on rates of extubation failure in mechanically ventilated preterm infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2016
CompletedFirst Posted
Study publicly available on registry
February 12, 2016
CompletedStudy Start
First participant enrolled
March 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedFebruary 25, 2020
September 1, 2017
1.8 years
February 10, 2016
February 22, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Extubation failure
Extubation failure criteria will be defined as follows: 1. Apnea (respiratory pause \>20 seconds), more than 6 episodes requiring physical stimulation in 6 hours or 1 requiring intermittent positive pressure ventilation. 2. Respiratory acidosis with pH \<7.25 and Peripheral arterial oxygen saturation (PaCO2) \>65 mmHg. ( \>15% sustained increase in FiO2 from extubation. 4. Cardiovascular collapse (heart rate \<60 beats per minute or shock. 5. Persistent marked/severe retractions. Extubation failure will be deemed to occur if any single criterion was met in any one of the 7 days after extubation. The decision to reintubate an infant and mechanical ventilation variables and subsequent extubation attempts after reintubation will be managed at the discretion of the clinical team.
the 7 days after extubation
Secondary Outcomes (8)
Mortality
within the 96 hour post-extubation period or at any time after with expected average of 5 weeks
Total duration of mechanical ventilation
During NICU admission with expected average of 5 weeks
Total duration of oxygen supplementation
During NICU admission with expected average of 5 weeks
Bronchopulmonary dysplasia (BPD)
at 36 weeks' post-menstrual age.
Severe BPD
at 36 weeks' post-menstrual age.
- +3 more secondary outcomes
Study Arms (2)
6 liter/min group
EXPERIMENTALInfants will be extubated to a HHHFNC (Fisher and Paykel Healthcare , Auckland, New Zealand) at flow rate of 6 L/min. Eligible infants will be enrolled while receiving mechanical ventilation. The timing of extubation will be determined by the clinical team and all infants will start caffeine prior to extubation.
3 liter/min group
ACTIVE COMPARATORInfants will be extubated to HHHFNC (Fisher and Paykel Healthcare , Auckland, New Zealand) a flow rate of 3 L/min. Eligible infants will be enrolled while receiving mechanical ventilation. The timing of extubation will be determined by the clinical team and all infants will start caffeine prior to extubation.
Interventions
Infants allocated to HHHFNC at 6 L/min. will be extubated to a HHHFNC flow of 6 L/min. Eligible infants will be enrolled while receiving mechanical ventilation. The timing of extubation will be determined by the clinical team and all infants will start caffeine prior to extubation.
Infants allocated to HHHFNC at 3 L/min. will be extubated to a HHHFNC flow of 3 L/min. Eligible infants will be enrolled while receiving mechanical ventilation. The timing of extubation will be determined by the clinical team and all infants will start caffeine prior to extubation.
Eligibility Criteria
You may qualify if:
- Infants born at less than 37 weeks' gestation, required endotracheal intubation and positive pressure ventilation, and are considered ready for extubation by the clinical team. Infants will be enrolled after written informed parental consent is obtained.
You may not qualify if:
- Suspected upper airway obstruction, congenital airway malformations, or major cardiopulmonary malformations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Neonatal Intensive Care Unit, Mansoura University Children Hospital
Al Mansurah, Dakahlia Governorate, 35516, Egypt
Related Publications (4)
Al-Mandari H, Shalish W, Dempsey E, Keszler M, Davis PG, Sant'Anna G. International survey on periextubation practices in extremely preterm infants. Arch Dis Child Fetal Neonatal Ed. 2015 Sep;100(5):F428-31. doi: 10.1136/archdischild-2015-308549. Epub 2015 Jun 10.
PMID: 26063193BACKGROUNDCollaborative Group for the Multicenter Study on Heated Humidified High-flow Nasal Cannula Ventilation. [Efficacy and safety of heated humidified high-flow nasal cannula for prevention of extubation failure in neonates]. Zhonghua Er Ke Za Zhi. 2014 Apr;52(4):271-6. Chinese.
PMID: 24915914BACKGROUNDCollins CL, Holberton JR, Barfield C, Davis PG. A randomized controlled trial to compare heated humidified high-flow nasal cannulae with nasal continuous positive airway pressure postextubation in premature infants. J Pediatr. 2013 May;162(5):949-54.e1. doi: 10.1016/j.jpeds.2012.11.016. Epub 2012 Dec 20.
PMID: 23260098BACKGROUNDCollins CL, Barfield C, Horne RS, Davis PG. A comparison of nasal trauma in preterm infants extubated to either heated humidified high-flow nasal cannulae or nasal continuous positive airway pressure. Eur J Pediatr. 2014 Feb;173(2):181-6. doi: 10.1007/s00431-013-2139-8. Epub 2013 Aug 18.
PMID: 23955516BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hesham Abdel-Hady
Mansoura University Children"s Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Pediatrics
Study Record Dates
First Submitted
February 10, 2016
First Posted
February 12, 2016
Study Start
March 1, 2016
Primary Completion
January 1, 2018
Study Completion
January 1, 2018
Last Updated
February 25, 2020
Record last verified: 2017-09
Data Sharing
- IPD Sharing
- Will not share